sy-3505
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 26, 2020 (NCT05257512)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06254599 | Phase 3 | May 1, 2024 | Government of China |
| NCT06037317 | Phase 1 | Oct 30, 2023 | Government of China |
| NCT05869162 | Phase 2 | Jun 30, 2023 | Government of China |
| NCT05257512 | Phase 1 | Apr 26, 2020 | Government of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 4 | 4 | 3 | 2020 |
1 organizations
Page 1 / 1